-
January 23, 2013
Novartis has posted a healthy set financials for the fourth quarter and revealed that chairman Daniel Vasella will step down to be replaced by Bayer's healthcare chief, and former Novartis executive, Joerg Reinhardt
Full story
-
November 08, 2012
Novartis has put the spotlight on its "industry-leading" pipeline, which contains more than 139 projects with 73 new compounds
Full story
-
January 25, 2012
Novartis has posted financials for the fourth quarter which show that net profit slumped 47% to $1.21 billion, hit by previously-disclosed charges of $900 million due to a likely decline in sales of the antihypertensive Tekturna
Full story
-
July 19, 2011
Novartis has posted a strong set of results for the second quarter, helped by the contribution from recently-acquired eye specialist Alcon and the healthy performance of its new drugs
Full story
-
June 02, 2011
Novartis' chief executive says the Swiss major could spend up to $3 billion on acquisitions to boost its consumer health, generics, biotech, veterinary and diagnostics businesses
Full story
-
October 21, 2010
Novartis has posted another strong set of financials for the third quarter this morning, boosted by its new drugs
Full story